Internal Medicine, Cardiovascular Disease · San Juan, PR
NPI
1952345944
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Carr #21 Blq U3#8, Las Lomas
San Juan, PR, 00921
Phone (787) 707-0542
Medicare paid, 2024
$34K
583 services
Medicare patients, 2024
174
Average age 77
Drug cost, 2024
$1.6M
23,942 prescriptions
Company payments, 2025
$312
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ivan S Ayala was code 99213 (office e&m - established), 303 times for 156 patients. In total Ivan S Ayala billed 583 services in 24 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 303 | 156 | $60.57 | $18K |
| 93000 Electrocardiogram | Office | 75 | 71 | $9.98 | $749 |
| 99211 Office E&M - Established | Office | 33 | 24 | $14.30 | $472 |
| 93306 Echocardiography (TTE/TEE) | Office | 31 | 30 | $142.27 | $4,410 |
| 99214 Office E&M - Established | Office | 23 | 23 | $78.00 | $1,794 |
| 99204 Office E&M - New | Office | 20 | 20 | $118.62 | $2,372 |
By year: 2022 $41K for 628 services; 2023 $36K for 571 services; 2024 $34K for 583 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ivan S Ayala prescribed most often to Medicare patients was Amlodipine Besylate, with 2,322 prescriptions and refills. In total Ivan S Ayala wrote 23,942 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 2,322 | 5,184 | 651 | $15K |
| Losartan Potassium Generic | 1,991 | 4,652 | 577 | $25K |
| Atorvastatin Calcium Generic | 1,461 | 3,341 | 406 | $16K |
| Metoprolol Succinate Generic | 1,411 | 3,041 | 382 | $25K |
| Rosuvastatin Calcium Generic | 1,239 | 3,033 | 372 | $18K |
| Ezetimibe Generic | 1,125 | 2,527 | 315 | $24K |
| Furosemide Generic | 694 | 1,370 | 194 | $3,916 |
| Synthroid Levothyroxine Sodium | 623 | 1,311 | 157 | $56K |
| Simvastatin Generic | 573 | 1,355 | 172 | $4,930 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 565 | 1,384 | 179 | $11K |
| Metformin Hcl Generic | 522 | 1,162 | 148 | $3,369 |
| Clopidogrel Clopidogrel Bisulfate | 511 | 1,049 | 136 | $7,042 |
| Levothyroxine Sodium Generic | 486 | 1,023 | 120 | $6,306 |
| Eliquis Apixaban | 480 | 690 | 113 | $404K |
| Hydrochlorothiazide Generic | 436 | 994 | 121 | $3,470 |
Brand drugs: - claims; generic drugs: 21,453 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ivan S Ayala $312 ($312 in general payments such as food, travel and fees) from 5 companies. The largest payer was Boston Scientific Corporation with $139.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.